APA
Padilla-Gutiérrez J. R., Palafox-Sánchez C. A., Valle Y., Orozco-Barocio G., Oregón-Romero E., Vázquez-Del Mercado M., Rangel-Villalobos H., Llamas-Covarrubias M. A. & Muñoz-Valle J. F. (20110513). Plasminogen activator inhibitor-1 polymorphisms (-844 G>A and HindIII C>G) in systemic lupus erythematosus: association with clinical variables. : Clinical and experimental medicine.
Chicago
Padilla-Gutiérrez Jorge Ramón, Palafox-Sánchez Claudia Azucena, Valle Yeminia, Orozco-Barocio Gerardo, Oregón-Romero Edith, Vázquez-Del Mercado Mónica, Rangel-Villalobos Héctor, Llamas-Covarrubias Mara Anaís and Muñoz-Valle José Francisco. 20110513. Plasminogen activator inhibitor-1 polymorphisms (-844 G>A and HindIII C>G) in systemic lupus erythematosus: association with clinical variables. : Clinical and experimental medicine.
Harvard
Padilla-Gutiérrez J. R., Palafox-Sánchez C. A., Valle Y., Orozco-Barocio G., Oregón-Romero E., Vázquez-Del Mercado M., Rangel-Villalobos H., Llamas-Covarrubias M. A. and Muñoz-Valle J. F. (20110513). Plasminogen activator inhibitor-1 polymorphisms (-844 G>A and HindIII C>G) in systemic lupus erythematosus: association with clinical variables. : Clinical and experimental medicine.
MLA
Padilla-Gutiérrez Jorge Ramón, Palafox-Sánchez Claudia Azucena, Valle Yeminia, Orozco-Barocio Gerardo, Oregón-Romero Edith, Vázquez-Del Mercado Mónica, Rangel-Villalobos Héctor, Llamas-Covarrubias Mara Anaís and Muñoz-Valle José Francisco. Plasminogen activator inhibitor-1 polymorphisms (-844 G>A and HindIII C>G) in systemic lupus erythematosus: association with clinical variables. : Clinical and experimental medicine. 20110513.